Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 8, 2011, Pages 1042-1045

  Kupferminc, Michael J ^a   Rimon, Eli ^a   Many, Ariel ^a   Sharon, Maslovitz ^a   Lessing, Joseph B ^a   Gamzu, Ronni ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

fetal growth restriction; inherited thrombophilias; low molecular weight heparin; placental abruption; Pregnancy; severe preeclampsia; stillbirth

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT DISEASE; SOLUTIO PLACENTAE; STILLBIRTH; THROMBOPHILIA;

ADULT; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RECURRENCE; RETROSPECTIVE STUDIES; THROMBOPHILIA;

EID: 79959934460     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.545911     Document Type: Article

References (26)

1. KupfermincMJ, EldorA, SteinmanN,ManyA, Bar-AmA, Jaffa A, Fait G, Lessing JB. Increased frequency of the genetic thrombophilia in women with complications of pregnancy. N Eng J Med 1999;340:9-13. (Pubitemid 29024678)
2. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, et al.Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-196.
3. Rodger MA. Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy. Thromb Res 2009;123 (Suppl 2):S100-S104.
4. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, Hague W, Rosene Montella K, Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008;112:320-324.
5. Sergio F, Maria Clara D, Gabriella F, Giorgia S, Sara De Carolis, Giancarlo P, Alessendro C. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 2006;25:115-127. (Pubitemid 44180352)
6. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005;45:86-91. (Pubitemid 40066419)
7. Surkan PJ, Stephansson O, Dickman PW, Cnattingius S. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. N Engl J Med 2004;350:777-785. (Pubitemid 38209647)
8. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, Rodger M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7:58-64.
9. Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G, Cochery- Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland ML, Dauzat M,Marès P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-3699. (Pubitemid 38596284)
10. Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, Zatti S, Benedetto C. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 2009;200:46.e1-46.e5.
11. Grandone E, De Stefano V, Rossi E, Cappucci F, Colaizzo D, Margaglione M. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis 2008;19:226-230. (Pubitemid 351498727)
12. Kupferminc Michael. Thrombophilia and adverse pregnancy outcome. 9th congress of Perinatal Medicine, Berlin, parallel session 11 Thrombophilia and pregnancy. J Perinat Med 2009;37 (Suppl 1):1-957.
13. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001;98:1041-1044. (Pubitemid 34075328)
14. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000;15:1830-1833. (Pubitemid 30636078)
15. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7:277-286.
16. Kupferrminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertens Pregnancy 2001;20:35-44. (Pubitemid 32672926)
17. Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80:49-54. (Pubitemid 29272019)
18. Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311-314. (Pubitemid 40668153)
19. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003;1:433-438.
20. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcomein thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693-697. (Pubitemid 30248516)
21. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799. (Pubitemid 40311367)
22. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008;112:359-372.
23. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002;13:364-368. (Pubitemid 36723587)
24. Ojeda NB, Grigore D, Alexander BT. Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 2008;15:101-106. (Pubitemid 351335411)
25. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006;49:257-269. (Pubitemid 44317914)
26. Spinillo A, Stronati M, Ometto A, Fazzi E, Lanzi G, Guaschino S. Infant neurodevelopmental outcome in pregnancies complicated by gestational hypertension and intra-uterine growth retardation. J Perinat Med 1993;21:195-203. (Pubitemid 23246214)